Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Cardiac imaging registry expands to include former NBA, NHL players
Former NBA player Muggsy Bogues, who also acted in the 1996 film Space Jam, is one of many athletes now participating in the registry. "I’ve lost too many friends to cardiovascular disease," he said.
CCTA delivers value, even when treating low-risk patients with no history of CAD
Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize.
MRI scans evaluate heart failure risk—no invasive catheterization required
Advanced imaging may be able to help certain heart patients avoid the risks and discomfort associated with right heart catheterizations.
New heart catheter for cell therapy delivery 1 step closer to FDA approval
The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue.
Reprocessed EP catheters recalled due to contamination risk
The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer.

Cardiac imaging registry expands to include former NBA, NHL players

Former NBA player Muggsy Bogues, who also acted in the 1996 film Space Jam, is one of many athletes now participating in the registry. "I’ve lost too many friends to cardiovascular disease," he said.

CCTA delivers value, even when treating low-risk patients with no history of CAD

Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize.

Researchers in the U.K. from Newcastle University, University of Leeds, and the University of East Anglia found they could use cardiovascular magnetic resonance (CMR) T2 intracardiac blood pool data to create imaging-derived SvO2 (iSvO2) noninvasively.

MRI scans evaluate heart failure risk—no invasive catheterization required

Advanced imaging may be able to help certain heart patients avoid the risks and discomfort associated with right heart catheterizations.

New heart catheter for cell therapy delivery 1 step closer to FDA approval

The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue.

Reprocessed EP catheters recalled due to contamination risk

The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer.

The HeartBeam AIMIGo device is approximately the size of a credit card and uses the company’s patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthesized 12-lead ECG.

ECG market keeps evolving thanks to AI, home monitoring and Epic integration

For years, the ECG market was relatively static. According to a new report, however, things are rapidly changing.

warning safety alert recall healthcare issue

Safety update: New recommendations for managing patients with high-risk defibrillation leads

HRS has shared an updated guidance on managing Boston Scientific defibrillation leads at risk of experiencing a significant malfunction. The issue, first reported in July 2025, is believed to impact approximately 350,000 leads still being used today.

Boston EP Party: Medtech companies share new electrophysiology data at AF Symposium 2026

AF Symposium 2026 in Boston included new data from some of the biggest names in electrophysiology. Johnson & Johnson MedTech, Abbott, Atraverse Medical, Field Medical, Pulse Biosciences, Argá Medtech SA and CardioFocus were just some of the medtech companies at the heart of late-breaking presentations.